Our unique study design combining frequent rRT-PCR and serological screening allowed for more complete ascertainment of illness burden

Our unique study design combining frequent rRT-PCR and serological screening allowed for more complete ascertainment of illness burden. Our study also had several limitations. and Rabacfosadine Delta (OR 14.6, 95%CI 5.7C37.5) variant illness were associated with improved HCIR. HCIR was related for symptomatic (21/110, 19%) and asymptomatic (195/775, 25%) index Continue Reading